The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation

被引：35

作者：

Schuurman, HJ

Schuler, W

Ringers, J

Jonker, M

机构：

[1] Novartis Pharma AG, Transplantat Res, Dept Transplantat Res, CH-4002 Basel, Switzerland

[2] Biomed Primate Res Ctr, Rijswijk, Netherlands

来源：

TRANSPLANTATION PROCEEDINGS | 1998年 / 30卷 / 05期

关键词：

D O I：

10.1016/S0041-1345(98)00589-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2198 / 2199

页数：2

共 4 条

[1] EVOLUTION OF MAJOR HISTOCOMPATIBILITY COMPLEX POLYMORPHISMS AND T-CELL RECEPTOR DIVERSITY IN PRIMATES [J].

BONTROP, RE ;

OTTING, N ;

SLIERENDREGT, BL ;

LANCHBURY, JS .

IMMUNOLOGICAL REVIEWS, 1995, 143 :33-62

[2]

NEUHAUS P, 1982, J MED PRIMATOL, V11, P155

[3] SDZ RAD, a new rapamycin derivative - Pharmacological properties in vitro and in vivo [J].

Schuler, W ;

Sedrani, R ;

Cottens, S ;

Haberlin, B ;

Schulz, M ;

Schuurman, HJ ;

Zenke, G ;

Zerwes, HG ;

Schreier, MH .

TRANSPLANTATION, 1997, 64 (01) :36-42

[4] SDZ RAD, a new rapamycin derivative - Synergism with cyclosporine [J].

Schuurman, HJ ;

Cottens, S ;

Fuchs, S ;

Joergensen, J ;

Meerloo, T ;

Sedrani, R ;

Tanner, M ;

Zenke, G ;

Schuler, W .

TRANSPLANTATION, 1997, 64 (01) :32-35

← 1 →